Karydas Daphne

COMPASS Pathways plc · Director

Karydas Daphne is listed in public filings as director. This Karydas Daphne insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include COMPASS Pathways plc (CMPS), and Mineralys Therapeutics, Inc. (MLYS). Investors use Karydas Daphne's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
COMPASS Pathways plcCMPS$250k21.1k sharesGrant / ExerciseMay 27, 2026$250.2K21.1k shares$11.85--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mineralys Therapeutics, Inc.MLYS$155k6.2k sharesSellMar 31, 2026$75.0K3k shares$25.00--
Mineralys Therapeutics, Inc.MLYS$111k9.2k sharesGrant / ExerciseMar 31, 2026$36.1K3k shares$12.02--
Mineralys Therapeutics, Inc.MLYS$233k8.3k sharesGrant / ExerciseFeb 19, 2026$232.9K8.3k shares$28.06--
Mineralys Therapeutics, Inc.MLYS--6.2k sharesGrant / ExerciseFeb 19, 2026Disclosure amount unavailable6.2k shares----
Mineralys Therapeutics, Inc.MLYS$224k4.9k sharesSellNov 13, 2025$463.4K10.1k shares$45.81--
Mineralys Therapeutics, Inc.MLYS$04.9k sharesSellNov 13, 2025$226.4K4.9k shares$46.36--
Mineralys Therapeutics, Inc.MLYS$153k15k sharesGrant / ExerciseNov 13, 2025$153.0K15k shares$10.20--
COMPASS Pathways plcCMPS$118k26k sharesGrant / ExerciseJun 12, 2025$117.5K26k shares$4.52--
Mineralys Therapeutics, Inc.MLYS$336k32.9k sharesGrant / ExerciseFeb 13, 2025$335.6K32.9k shares$10.20--